Skip to content

Clinical trials

Phase 2 Neuroblastoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Phase 2 Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20131
20152
20161
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Cologne2
Children's Hospital Medical Center, Cincinnati1
European Organisation for Research and Treatment of Cancer - EORTC1
German Society for Pediatric Oncology and Hematology GPOH gGmbH1
Pfizer1
University Hospital Muenster1
University Medicine Greifswald1
University of Regensburg1
Y-mAbs Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma10
Neoplasms3
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Sarcoma2
Ataxia Telangiectasia1
Blast Crisis1
Bone Neoplasms1
Breast Neoplasms1
Burkitt Lymphoma1
Carcinoma, Ovarian Epithelial1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.